tiprankstipranks
Helen Of Troy Limited (HELE)
NASDAQ:HELE

Helen Of Troy (HELE) AI Stock Analysis

436 Followers

Top Page

HELE

Helen Of Troy

(NASDAQ:HELE)

Select Model
Select Model
Select Model
Neutral 46 (OpenAI - 5.2)
Rating:46Neutral
Price Target:
$14.50
▼(-13.33% Downside)
Action:ReiteratedDate:01/09/26
The score is primarily constrained by weak financial performance, driven by sharp TTM earnings deterioration and revenue pressure, with only partial support from positive cash flow. The earnings call reinforced near-term risk via lowered EPS guidance, tariff/pricing headwinds, and leverage/inventory pressures, while technical indicators show only modest stabilization and valuation support is limited due to loss-making results and no dividend yield.
Positive Factors
Resilient Gross Margin
Helen of Troy’s mid-to-high 40% gross margins provide a durable profit cushion across cycles. This margin profile suggests persistent product-level pricing power and favorable mix in branded consumer goods, helping preserve gross profitability while management executes recovery and supply-chain fixes.
Negative Factors
Sharp Profit Decline
The swing from prior profitability to steep TTM losses and multi-year revenue declines indicates structural demand weakness or mix deterioration. Persistent negative margins erode equity returns, raise impairment risk, and limit the company’s ability to reinvest for growth until demand and pricing stabilize.
Read all positive and negative factors
Positive Factors
Negative Factors
Resilient Gross Margin
Helen of Troy’s mid-to-high 40% gross margins provide a durable profit cushion across cycles. This margin profile suggests persistent product-level pricing power and favorable mix in branded consumer goods, helping preserve gross profitability while management executes recovery and supply-chain fixes.
Read all positive factors

Helen Of Troy (HELE) vs. SPDR S&P 500 ETF (SPY)

Helen Of Troy Business Overview & Revenue Model

Company Description
Helen of Troy Limited provides various consumer products in the United States, Canada, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. The company operates through three segments: Home & Outdoor, Health & Wellness, and Beauty...
How the Company Makes Money
Helen of Troy primarily makes money by selling branded consumer products to retail customers (e.g., mass retailers, specialty retailers, and e-commerce channels) and, to a lesser extent, through direct-to-consumer sales via brand websites. Revenue...

Helen Of Troy Key Performance Indicators (KPIs)

Any
Any
Revenue By Segment
Revenue By Segment
Chart Insights
Data provided by:The Fly

Helen Of Troy Financial Statement Overview

Summary
Income statement weakness dominates: revenue has been declining and TTM profitability deteriorated sharply into steep losses, despite relatively steady gross margin. The balance sheet is mixed with concerns from negative returns and recent capital-structure shifts, while cash flow is a partial offset with positive TTM operating and free cash flow but uneven conversion historically.
Income Statement
22
Negative
Balance Sheet
45
Neutral
Cash Flow
58
Neutral
BreakdownTTMFeb 2025Feb 2024Feb 2023Feb 2022Feb 2021
Income Statement
Total Revenue1.80B1.91B2.01B2.07B2.22B2.10B
Gross Profit841.97M914.41M948.66M899.35M953.19M927.30M
EBITDA-198.85M268.61M301.32M286.94M310.88M328.61M
Net Income-792.50M123.75M168.59M143.27M223.76M253.95M
Balance Sheet
Total Assets2.34B3.13B2.84B2.91B2.82B2.26B
Cash, Cash Equivalents and Short-Term Investments29.74M18.87M18.50M29.07M33.38M45.12M
Total Debt946.88M956.84M702.93M977.08M856.96M381.98M
Total Liabilities1.49B1.45B1.20B1.42B1.50B1.02B
Stockholders Equity852.26M1.68B1.64B1.49B1.33B1.24B
Cash Flow
Free Cash Flow80.70M83.14M269.42M33.38M62.78M215.44M
Operating Cash Flow94.79M113.21M306.07M208.24M140.82M314.11M
Investing Cash Flow-266.56M-263.09M5.45M-319.33M-438.91M-98.67M
Financing Cash Flow158.11M150.25M-322.09M106.78M286.35M-194.78M

Helen Of Troy Technical Analysis

Technical Analysis Sentiment
Neutral
Last Price16.73
Price Trends
50DMA
16.60
Positive
100DMA
18.13
Negative
200DMA
20.72
Negative
Market Momentum
MACD
-0.10
Negative
RSI
58.53
Neutral
STOCH
85.70
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HELE, the sentiment is Neutral. The current price of 16.73 is above the 20-day moving average (MA) of 15.32, above the 50-day MA of 16.60, and below the 200-day MA of 20.72, indicating a neutral trend. The MACD of -0.10 indicates Negative momentum. The RSI at 58.53 is Neutral, neither overbought nor oversold. The STOCH value of 85.70 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for HELE.

Helen Of Troy Risk Analysis

Helen Of Troy disclosed 28 risk factors in its most recent earnings report. Helen Of Troy reported the most risks in the "Legal & Regulatory" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

Helen Of Troy Peers Comparison

Overall Rating
UnderperformOutperform
Sector (62)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
74
Outperform
$30.07M13.4419.09%9.81%-18.29%-43.76%
68
Neutral
$1.86B12.425.52%3.15%-5.21%1.96%
62
Neutral
$20.33B14.63-3.31%3.23%1.93%-12.26%
55
Neutral
$361.91M2.9620.36%2.39%-12.10%
52
Neutral
$1.04B-3.02-2.50%3.51%-1.34%-73.59%
46
Neutral
$386.00M-1.34-67.60%-5.64%-577.74%
45
Neutral
$114.71M-5.47-15.42%-13.14%57.98%
* Consumer Defensive Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
HELE
Helen Of Troy
16.73
-16.89
-50.24%
NUS
Nu Skin
7.52
1.58
26.62%
SPB
Spectrum Brands Holdings
79.04
19.56
32.89%
UG
United-Guardian
6.55
-0.97
-12.90%
EPC
Edgewell Personal Care
21.89
-7.34
-25.11%
SKIN
Beauty Health
0.90
-0.10
-10.30%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Jan 09, 2026